Electrophysiological phenotyping in genetically engineered mice

Physiological Genomics

Volumn 13, Issue , 2003, Pages 207-216

  Berul, Charles I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Animal model; Arrhythmias; Electrophysiology; Molecular biology

Indexed keywords

GAP JUNCTION PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL;

ANIMAL MODEL; ARRHYTHMOGENESIS; CARDIOMYOPATHY; CONFERENCE PAPER; CONGENITAL HEART DISEASE; ELECTROPHYSIOLOGY; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; GENOMICS; HEART ARRHYTHMIA; HEART CONDUCTION; HEART DEATH; HUMAN; LONG QT SYNDROME; MAMMAL; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; TRANSGENE; ANIMAL; CARDIOVASCULAR DISEASE; DISEASE MODEL; GENETICS; METHODOLOGY; REVIEW;

ANIMALIA; MAMMALIA; MURINAE;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; GENETIC ENGINEERING; MICE; PHENOTYPE;

EID: 0038387491     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00183.2002     Document Type: Conference Paper

References (80)

1. Ackerman MJ and Clapham DE. Ion channels: basic science and clinical disease. N Engl J Med 336: 1575-1586, 1997.
2. Baker LC, London B, Choi BR, Koren G, and Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86: 396-407, 2000.
3. Battey J, Jordan E, Cox D, and Dove W. An action plan for mouse genomics. Nat Genet 21: 73-75, 1999.
4. Benson DW, Sharkey A, Fatkin D, Lang P, Basson CT, McDonough B, Strauss AW, Seidman JG, and Seidman CE. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation 97: 2043-2048, 1997.
5. Berul CI, Aronovitz MJ, Wang PJ, and Mendelsohn ME. In vivo cardiac electrophysiology studies in the mouse. Circulation 94: 641-2648, 1996.
6. Berul CI, Christe ME, Aronovitz MJ, Seidman CE, Seidman JG, and Mendelsohn ME. Electrophysiological abnormalities and arrhythmias in α-MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest 99: 570-576, 1997.
7. Berul CI, Christe ME, Aronovitz MJ, Maguire CT, Seidman CE, Seidman JG, and Mendelsohn ME. Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. J Interv Card Electrophysiol 2: 7-14, 1998.
8. Berul CI. A gap in understanding the connection between connexins and conduction. J Cardiovasc Electrophysiol 10: 1376-1379, 1999.
9. Berul CI, McConnell BK, Wakimoto H, Moskowitz IPG, Maguire CT, Semsarian C, Vargas MM, Gehrmann J, Seidman CE, and Seidman JG. Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant myosin binding protein C gene. Circulation 104: 2734-2739, 2001.
10. Bevilacqua LM, Maguire CT, Seidman CE, Seidman JG, and Berul CI. QT dispersion in α-myosin heavy-chain familial hypertrophic cardiomyopathy mice. Pediatr Res 45: 643-647, 1999.
11. Bevilacqua LM, Simon AM, Maguire CT, Gehrmann J, Wakimoto H, Paul DL, and Berul CI. A targeted disruption in connexin40 leads to distinct atrioventricular conduction defects. J Interv Card Electrophysiol 4: 459-467, 2000.
12. Beyer EC, Davis LM, Saffitz JE, and Veenstra RD. Cardiac intercellular communication: consequences of connexin distribution and diversity. Braz J Med Biol Res 28: 415-425, 1995.
13. Binah O, Arieli R, Beck R, Rosen MR, and Palti Y. Ventricular electrophysiological properties: is interspecies variability related to thyroid state? Am J Physiol Heart Circ Physiol 252: H1265-H1274, 1987.
14. Brugada R and Roberts R. The molecular genetics of arrhythmias and sudden death. Clin Cardiol 21: 553-60, 1998.
15. Chang AC, McAreavey, D, and Fananapazir L. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death. Curr Opin Cardiol 10: 9-15, 1995.
16. Clapham DE and Neer EJ. G protein βγ subunits. Annu Rev Pharmacol Toxicol 37: 167-203, 1997.
17. Coppen SR, Dupont E, Rothery S, and Severs NJ. Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 82: 232-243, 1998.
18. Coromilas J, Saltman AE, Waldecker B, Dillon SM, and Wit AL. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts. Circulation 91: 2245-2263, 1995.
19. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 7: 999-1007, 1996.
20. DeBakker MJ, van Capelle FJ, and Janse MJ. Slow conduction in the infarcted human heart. "Zigzag" course of activation. Circulation 88: 915-926, 1993.
21. Dillon SM, Kerner TE, Hoffman J, Menz V, Li KS, and Michele JJ. A system for in vivo cardiac optical mapping. IEEE Eng Med Biol Mag 17: 95-108, 1998.
22. Doevendans PA, Daemen MJ, deMuinck ED, and Smits JF. Cardiovascular phenotyping in mice. Cardiovasc Res 39: 34-49, 1998.
23. + channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res 83: 95-102, 1998.
24. Drici MD, Burklow TR, Haridasse V, Glazer RI, and Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94: 1471-1474, 1996.
25. El-Sherif N and Turitto G. The long QT syndrome and torsades de pointes. Pacing Clin Electrophysiol 22: 91-110, 1999.
26. Fewell JG, Osinska H, Klevitsky R, Ng W, Sfyris G, Bahrehmand F, and Robbins J. A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice. Am J Physiol Heart Circ Physiol 273: H1595-H1605, 1997.
27. Garrey WE. The nature of fibrillatory contraction of the heart: its relation to tissue mass and form. Am J Physiol 33: 397-414, 1914.
28. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, and Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 732-734, 1996.
29. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, and Berul CI. Phenotypic screening for heart rate variability in mice. Am J Physiol Heart Circ Physiol 279: H733-H740, 2000.
30. Gehrmann J and Berul CI. Cardiac electrophysiology in genetically-engineered mice. J Cardiovasc Electrophysiol 11: 354-368, 2000.
31. Gehrmann J, Frantz S, Maguire CT, Vargas M, Ducharme A, Wakimoto H, Lee RT, and Berul CI. Electrophysiological characterization of murine myocardial ischemia and infarction. Basic Res Cardiol 96: 237-250, 2001.
32. Gehrmann J, Meister M, Maguire CT, Hammer PE, Neer EJ, Berul CI, and Mende U. Impaired parasympathetic heart rate control in transgenic mice with a reduction of functional G-protein β-subunits. Am J Physiol Heart Circ Physiol 282: H445-H456, 2002; 10.1152/ajpheart.00565.2001.
33. Gray RA, Jalife J, Panfilov A, Baxter WT, Cabo C, Davidenko JM, and Pertsov AM. Nonstationary vortexlike reentrant activity as a mechanism of polymorphic ventricular tachycardia in the isolated rabbit heart. Circulation 91: 2454-2469, 1995.
34. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, and Saffitz JE. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest 99: 1991-1998, 1997.
35. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, and Willecke K. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99: 1508-1515, 1999.
36. Han X, Kobzik L, Severson D, and Shimoni Y. Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node. J Physiol 509: 741-754, 1998.
37. + channel in the heart. Modal regulation by G protein βγ subunits. J Gen Physiol 112: 199-210, 1998.
38. James JF, Hewett TE, and Robbins J. Cardiac physiology in transgenic mice. Circ Res 82: 407-415, 1998.
39. Janse MJ, Opthof T, and Kleber AG. Animal models of cardiac arrhythmias. Cardiovasc Res 39: 165-177, 1998.
40. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, and Robbins J. Ablation of the murine a myosin heavy chain leads to dosage effects and functional deficits in the heart. J Clin Invest 98: 1906-1917, 1996.
41. Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM, and Berger RD. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest 102: 1279-1285, 1998.
42. Kasahara H, Wakimoto H, Liu M, Maguire CT, Converso KL, Shioi T, Huang WY, Manning WJ, Paul D, Lawitts J, Berul CI, and Izumo S. Progressive atrioventricular conduction defects and heart failure in mice expressing Csx/Nkx2.5 homeodomain mutant protein. J Clin Invest 108: 189-201, 2001.
43. Knisley SB. Optical mapping of cardiac electrical stimulation. J Electrocardiol 30: 11-17, 1998.
44. KAch in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 37: 2136-2143, 2001.
45. Kramer K, van Acker SA, Voss HP, Grimbergen JA, van der Vijgh WJ, and Bast A. Use of telemetry to record electrocardiogram and heart rate in freely moving mice. J Pharmacol Toxicol Methods 30: 209-215, 1993.
46. KAch. J Biol Chem 270: 29059-29062, 1995.
47. Kupershmidt S, Yang T, Anderson ME, Wessels A, Niswender KD, Magnuson MA, and Roden DM. Replacement by homologous recombination of the minK gene with lacZ reveals restriction on minK expression to the mouse cardiac conduction system. Circ Res 84: 146-152, 1999.
48. Laurita K, Girouard SD, Rudy Y, and Rosenbaum DS. Role of passive electrical properties during action potential restitution in intact heart. Am J Physiol Heart Circ Physiol 273: H1205-H1214, 1997.
49. London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell GF, and Koren G. Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci USA 95: 2926-2931, 1998.
50. Luke RA and Saffitz JE. Remodeling of ventricular conduction pathway in healed canine infarct border zones. J Clin Invest 87: 1594-1602, 1991.
51. Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, and Smits JF. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 41: 586-593, 1999.
52. Maguire CT, Bevilacqua LM, Wakimoto H, Gehrmann J, and Berul CI. Maturational atrioventricular nodal physiology in the mouse. J Cardiovasc Electrophysiol 11: 557-564, 2000.
53. Mandapati R, Asano Y, Baxter WT, Gray R, Davidenko J, and Jalife J. Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart. Circulation 98: 1688-1696, 1998.
54. Mandorla S and Martino C. Familial atrial septal defect with atrioventricular conduction defects. G Ital Cardiol 28: 294-296, 1998.
55. Mansier P, Medigue C, Charlotte N, Vermeiren C, Coraboeuf E, Deroubai E, Ratner E, Chevalier B, Clairambault J, Carre F, Dahkli T, Bertin B, Briand P, Strosberg D, and Swynghedauw B. Decreased heart rate variability in transgenic mice overexpressing atrial β1-adrenoceptors. Am J Physiol Heart Circ Physiol 271: H1465-H1472, 1996.
56. Mitchell GF, Jeron A, and Koren G. Measurements of heart rate and QT interval in the conscious mouse. Am J Physiol Heart Circ Physiol 274: H747-H751, 1998.
57. O'Brien SE, Apkon MA, Berul CI, Patel HT, Saupe K, Spindler M, Ingwall JS, and Zahler RX. Phenotypic features of long QT syndrome in transgenic mice expressing human α3 Na-K-ATPase isoform in hearts. Am J Physiol Heart Circ Physiol 279: H2133-H2142, 2000.
58. Peters NS and Wit AL. Myocardial architecture and ventricular arrhythmogenesis. Circulation 97: 1746-1754, 1998.
59. Peters NS. Gap junctions and clinical cardiology: from molecular biology to molecular medicine. Eur Heart J 18: 1697-1702, 1997.
60. Priori SG, Barhanin J, Hauer RN, Haverkamp W, Jongsma HJ, Kleber AG, McKenna WJ, Roden DM, Rudy Y, Schwartz K, Schwartz PJ, Towbin JA, and Wilde AM. Genetic and molecular bases of cardiac arrhythmias: impact on clinical management: parts I and II. Circulation 99: 518-528, 1999.
61. Priori SG, Schwartz PJ, Napolitano C, Bianchi L, Dennis A, De Fusco M, Brown AM, and Casari G. A recessive variant of the Romano-Ward long QT syndrome? Circulation 97: 2420-2425, 1998.
62. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, and Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831-1834, 1995.
63. Sakmann B, Noma A, and Trautwein W. Acetylcholine activation of single muscarinic K channels in isolated pacemaker cells of the mammalian heart. Nature 303: 250-253, 1983.
64. Schaper W and Winkler B. Of mice and men: the future of cardiovascular research in the molecular era. Cardiovasc Res 39: 3-7, 1998.
65. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, and Seidman JG. Congenital heart disease caused by mutations in the transcription factor Nkx2.5. Science 281: 108-111, 1998.
66. Simon AM, Goodenough DA, and Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of first-degree atrioventricular block and bundle branch block. Curr Biol 8: 295-298, 1998.
67. Skanes AC, Mandapati R, Berenfeld O, Davidenko JM, and Jalife J. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 98: 1236-1248, 1998.
68. Spach MS. Alignment of myocardial cells and its role in the genesis of cardiac arrhythmias. Pacing Clin Electrophysiol 13: 1535-1540, 1990.
69. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, and Keating MT. Mutations in the mink gene cause long QT syndrome and suppress IKs function. Nat Genet 17: 338-340, 1997.
70. Sumeray MS and Yellon DM. Characterization and validation of a murine model of global ischaemia-reperfusion injury. Mol Cell Biochem 186: 61-68, 1998.
71. Tanaka M, Berul CI, Douglas P, Mudd JO, Seidman CE, Seidman JG, and Izumo S. A mouse model for familial atrial septal defect associated with arrhythmia generated by gene targeting of the cardiac transcription factor Csx/Nkx2.5 (Abstract). Circulation 100: I59, 1999.
72. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, and Ross J Jr. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94: 1109-1117, 1996.
73. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, and Saffitz JE. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation 97: 686-691, 1998.
74. sα. Circ Res 82: 416-423, 1998.
75. Wakimoto H, Maguire CT, Kovoor P, Gehrmann J, and Berul CI. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc Res 50: 463-473, 2001.
76. Wakimoto H, Kasahara H, Maguire CT, Izumo S, and Betul CI. Developmentally modulated cardiac conduction failure in transgenic mice with fetal or postnatal overexpression of DNA non-binding mutant Nkx2.5. J Cardiovasc Electrophysiol 13: 682-688, 2002.
77. Wang L and Duff HJ. Developmental changes in transient outward current in mouse ventricle. Circ Res 81: 120-127, 1997.
78. Wickman K, Nemec J, Gendler SJ, and Clapham DE. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20: 103-114, 1998.
79. Witkowski FX, Clark RB, Larsen TS, Melnikov A, and Giles WR. Voltage-sensitive dye recordings of electrophysiological activation in a Langendorff-perfused mouse heart. Can J Cardiol 13: 1077-1082, 1997.
80. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, and Robbins J. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Circ Res 85: 841-847, 1999.